SCHEMBL11027686

SCHEMBL11027686

CCOC(=O)C(Cl)c1cccs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.41
ALOX5 P09917 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 5/20 0.40
KEAP1 Q14145 2/20 0.40
HPGD P15428 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 1/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
GSK3B P49841 1/20 0.40
PIN1 Q13526 1/20 0.39
KMT2A Q03164 2/20 0.39
TSHR P16473 1/20 0.39
PKM P14618 1/20 0.39
MME P08473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1432886 0.83 MMP8 (0.45) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL1695960 0.81 KEAP1 (0.53) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL3407961 0.81 ALOX5 (0.45) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL4398618 0.80 ALOX5 (0.41) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL6032863 0.80 ALOX5 (0.44) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL25358790 0.80 MME (0.43) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL17724568 0.80 ALOX5 (0.41) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
Hydrochloric Acid SCHEMBL28191013 0.80 MMP8 (0.43) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL3173895 0.80 ALOX5 (0.41) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1
SCHEMBL28746590 0.80 ALOX5 (0.41) RORCALOX5SMN1; SMN2HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2891655-A1 Anilides-alkylthioethers as ACAT inhibitors for the treatment de dermatological diseases PIERRE FABRE MEDICAMENT (FR) 2015-07-08 EP disclosed
EP-2694477-A1 ANILIDE-ALKYL THIOETHERS AS ACAT INHIBITORS FOR THE TREATMENT OF DERMATOLOGICAL DISEASES Pierre Fabre Medicament (FR) 2014-02-12 EP disclosed
WO-2012136711-A1 ANILIDE-ALKYL THIOETHERS AS ACAT INHIBITORS FOR THE TREATMENT OF DERMATOLOGICAL DISEASES PIERRE FABRE MEDICAMENT (FR) 2012-10-11 WO disclosed
EP-0044119-B1 PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE STAMICARBON B.V. (NL) 1985-05-29 EP disclosed
US-4435552-A COORDINATION CATALYST CONTAINING HALOACYL COMPOUND STAMICARBON B.V. (NL) 1984-03-06 US disclosed
EP-0044119-A2 Process for the preparation of copolymers of ethylene with at least one other 1-alkene STAMICARBON B.V. (NL) 1982-01-20 EP disclosed